| 000 | 01134 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515224709.0 | ||
| 264 | 0 | _c20100908 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1558-3163 | ||
| 024 | 7 |
_a10.1016/j.rdc.2010.03.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPlenge, Robert M | |
| 245 | 0 | 0 |
_aLeveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bRheumatic diseases clinics of North America _cMay 2010 |
||
| 300 |
_a259-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPharmacogenetics _xmethods |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aRaychaudhuri, Soumya | |
| 773 | 0 |
_tRheumatic diseases clinics of North America _gvol. 36 _gno. 2 _gp. 259-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.rdc.2010.03.002 _zAvailable from publisher's website |
| 999 |
_c19862448 _d19862448 |
||